Ms. Oishi Mukherjee

Ms. Oishi Mukherjee

Junior Research Fellow
  • Oral presentation on “A chemotherapeutic drug, Doxorubicin-induced epigenetic regulation of dendritic cell (DC) maturation to elicit anti-tumor activity in non-small cell lung cancer (NSCLC)” at 4th EBCCON-2023, SRM Medical College Hospital & Research Centre, Kattankulathur.
  • Served as a volunteer during the Faculty Development Program on Mammalian Cell Culture and Molecular Expression Techniques organized by the Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, 2023.
  • Participated in the Hands-on workshop on FACS, 2022, in association with DST-FIST, Govt. of India and supported by B.D. India Pvt. Ltd. organized by the Department of Biotechnology. School of Bioengineering, SRM Institute of Science and Technology. Kattankulathur, 2022.
  • Oral presentation on “A chemotherapeutic drug, Doxorubicin-induced epigenetic regulation of dendritic cell (DC) maturation to elicit anti-tumor activity in non-small cell lung cancer (NSCLC)” at the 3rd International Cappadocia Scientific Research Congress, 2022.
  • Oral Presentation on “Involvement of Neem Leaf Glycoprotein (NLGP) In Suppression Of Regulatory T (Treg) With Concomitant Release Of Nitric Oxide In Non-Small Cell Lung Cancer (NSCLC)” at the International Collagen Symposium, 2022, CLRI, Chennai.
  • Online non-credit course authorized by Rice University and offered through Coursera on “Fundamentals of Immunology: Innate Immunity and B-Cell Function”.
  • Doxorubicin-induced epigenetic regulation of dendritic cell maturation in association with T cell activation facilitates anti-tumor activity in non-small cell lung cancer (NSCLC). (Accepted in Pathology-Research and Practice; DOI: https://doi.org/10.1016/j.prp.2023.155004 ).
  • Association of Wiskott Aldrich Syndrome protein (WASp) in epigenetic regulation of B cell differentiation in Non-Small Cell Lung Cancer (NSCLC); (Accepted in PathologyResearch and Practice; DOI: https://doi.org/10.1007/s12032-023-02264-7.
  • Immunomodulatory effects of Diospyros peregrina fruit preparation (DFP) in Non-Small Cell Lung Cancer (NSCLC) by utilizing dendritic cell-mediated antigen presentation and T helper (Th) cell differentiation (Accepted in Medical Oncology)